A detailed description of the pipeline, methods, and results can be found in the following article: Giraud-Sauveur, F., Blampey, Q., Benkirane, H. et al. STHELAR, a multi-tissue dataset linking ...

Spatial biology is a rapidly advancing discipline that examines biological molecules (such as DNA, RNA, and proteins) within their native locations in tissues. This approach offers critical insight ...

In this post, we will show you how to enable or disable Spatial Sound in Windows 11. Spatial Sound is an advanced audio feature that creates an immersive, 3D sound experience, without requiring ...

The rapid development of spatial transcriptomics (ST) technologies has greatly advanced the understanding of gene expression, tissue architecture, cellular composition, and disease mechanisms within ...

Abstract: Recent advancements in spatial transcriptomics technology have enabled the capture of gene expression profiles while maintaining spatial information. Accurately identifying spatial ...

Foster City, Calif. | January 27, 2026 — Signios Bio today announced the launch of a new grant program supporting innovative spatial transcriptomics research using the 10x Genomics Xenium 5K Spatial ...

In 1950, when computing was little more than automated arithmetic and simple logic, Alan Turing asked a question that still reverberates today: can machines think? It took remarkable imagination to ...

Turning a boring 2D photo into a more dynamic, 3D-like viewing experience might sound impossible. But you can do it right from your phone running iOS 26, thanks to Apple's new Spatial Scenes. Apple's ...

Apple has introduced two interesting ways to view photos across its platforms, Spatial Photos and Spatial Scenes, and each adds depth in its own way. Here are the differences and what you need to know ...

A comprehensive review article titled “Bioinformatics perspectives on transcriptomics: A comprehensive review of bulk and single-cell RNA sequencing analyses,” published in Quantitative Biology, ...

Background Most patients with biliary tract cancer (BTC) do not derive durable clinical benefit (DCB) from immune checkpoint inhibitors (ICIs), underscoring the urgent need for predictive biomarkers.